OHRP - OHR Pharmaceutical, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 512.42M
Enterprise Value 38.61M
Trailing P/E N/A
Forward P/E 1-0.27
PEG Ratio (5 yr expected) 1-0.01
Price/Sales (ttm)N/A
Price/Book (mrq)0.70
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-0.58

Financial Highlights

Fiscal Year

Fiscal Year Ends Sep 30, 2017
Most Recent Quarter (mrq)Mar 31, 2018


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-44.50%
Return on Equity (ttm)-85.35%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
Net Income Avi to Common (ttm)-15.48M
Diluted EPS (ttm)-0.2780
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)5.22M
Total Cash Per Share (mrq)0.09
Total Debt (mrq)287.9k
Total Debt/Equity (mrq)1.63
Current Ratio (mrq)3.37
Book Value Per Share (mrq)0.31

Cash Flow Statement

Operating Cash Flow (ttm)-17.11M
Levered Free Cash Flow (ttm)-12.78M

Trading Information

Stock Price History

Beta -0.55
52-Week Change 3-64.57%
S&P500 52-Week Change 313.49%
52 Week High 32.1800
52 Week Low 30.1800
50-Day Moving Average 30.2154
200-Day Moving Average 30.4758

Share Statistics

Avg Vol (3 month) 3608.02k
Avg Vol (10 day) 32.32M
Shares Outstanding 556.47M
Float 52.17M
% Held by Insiders 14.43%
% Held by Institutions 114.41%
Shares Short 31.89M
Short Ratio 37.48
Short % of Float 33.70%
Shares Short (prior month) 31.84M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/3
Last Split Date 3Jun 3, 2013